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Abstract 
 
The Impact of Increased Collateral Flow on Transverse Arteriolar Microvascular 
Tree Morphology 
 
David Danzeiser 
 
 The goal of this study was to understand how arteriogenesis impacts 
transverse arteriolar tree structure. The previous process involved a vascular 
casting technique that utilized black India ink as the casting agent and manual 
measurement of vessel morphology with ImageJ. This study decreased the 
complexity of the casted samples by using a casting compound called Microfil. 
Microfil’s viscosity can be adjusted and through experimentation, a viscosity was 
found that stopped at the capillary level, allowing only the arterial side of the 
circulation to be casted. A macro in ImageJ was written to help with 
morphological measurement by bundling vessel length and diameter into one 
measurement instead of two. These two adjustments were then used in a ligated 
mouse model to compare healthy and remodeled vascular networks. The 
analysis revealed that the only significant difference for length and diameter 
measurements was in the diameters of the collateral. This indicates that it’s 
possible that stimulating arteriogenesis in a clinical environment should not 
cause any negative effects in the collateral-containing muscle. However, this 
observation is potentially limited by the differences between the model and 
patient.  
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Chapter 1 - Introduction 
Normal Function of Circulatory System 
Overview 
The primary function of the circulation is to carry out nutrient and waste 
exchange in all of the body tissues, and the rate of blood flow is controlled by 
tissue demand for oxygen and nutrients. Additional functions include the 
transport of endocrine factors, thermoregulation, and inflammation (17, 24, 32). 
The blood flow and circulation in the body are divided into the systemic 
circulation and the pulmonary circulation, the systemic circulation is also known 
as the peripheral circulation (Figure 1) (17). 
Figure 1 – Basic circulatory patterns of blood flow. Adapted 
from (9). 
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The pump that creates the circulatory flow is the heart. The human heart is 
made up of 4 major chambers: the right atrium, right ventricle, left atrium and left 
ventricle (17, 32). The heart also has 4 valves; each valve is unidirectional and 
keeps blood in the heart flowing in the one direction. The valves are made up of 
two or three small but strong flaps of connective tissue called leaflets. The 
leaflets open to allow blood to flow through the valve and close to prevent blood 
from flowing backwards (17, 32), depending on blood pressure gradients across 
their location. The tricuspid valve is positioned between the right atrium and the 
right ventricle.  The pulmonic valve separates the right ventricle from the 
pulmonary artery. The mitral valve is positioned between the left atrium and the 
left ventricle and the aortic valve separates the left ventricle from the aorta 
(Figure 2). 
Figure 2: Human Heart Diagram, adapted from (21) 
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The process of blood circulation begins with the right side of the heart 
receiving blood that is low in oxygen from the vena cava, which drains veins from 
all over the body. It then pumps the blood through the pulmonary arteries into the 
lungs where it will become oxygenated. The oxygenated blood then leaves the 
heart from the aorta and travels through a branching system of arteries and 
arterioles; from the arterioles the blood travels into capillaries, the site of nutrient 
and waste exchange, before moving into venules; the venules gradually coalesce 
into veins, which bring the deoxygenated blood back to the vena cava and right 
atrium to form a continuous circulation (3, 12, 17). At each order of branching, 
the sizes of the vessels decrease but the number of individual vascular entities 
increases (12, 17) and all blood in the human body will traverse the full circuit an 
average of once each minute when the body is at rest and as many as six times 
each minute during physically activity (17).   
 The role of the arteries is to transport blood under high pressure and 
velocity to the tissues, compared to the veins, which transport blood at high 
velocities but low pressures and thus form the capacitance vessels of the 
circulation (as much as 60% of a person’s blood volume can be found in the 
veins at rest). The arterioles are the last of the small branches of the arterial 
system before blood flows into the capillaries (32), the primary site of nutrient and 
waste exchange between the blood and the interstitium/parenchyma. The 
venules then collect the blood from the capillaries as they gradually coalesce into 
veins. Veins take the deoxygenated blood back to the heart to be oxygenated by 
the lungs and also serve as a major reservoir of extra blood (17).  
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Microcirculation 
As stated earlier, the most important functions of the circulation occur in 
the microcirculation. This is due to the fact that the microcirculation is the site of 
nutrient and waste exchange. Capillary blood flow is determined at the upstream 
arterioles, based on the contractile state of smooth muscle cells that encircle the 
arterioles. Smooth muscle cells control arteriolar diameter by either contracting to 
constrict arterioles and decrease blood flow, or relaxing to dilate the arterioles 
and increase blood flow. Arterioles have the potential to drastically changing the 
blood flow in response to tissue needs (17) because according to Poiseuille’s 
Law, diameter is the largest contributing factor to blood flow:   
     
   
, where F 
is the rate of blood flow, P is the pressure difference between the ends of the 
vessel, r is the radius of the vessel,  is the viscosity of the blood, and l is the 
length of the vessel. It is important to note that blood flow is proportional to the 
fourth power of the radius of the vessel, which is why it is the largest factor when 
determining blood flow for the tissue for which it is supplying blood (17). The 
arterioles will branch until they reach diameters of 5 to 9 micrometers where they 
transition to capillaries (32). The walls of the capillaries are extremely thin, 
constructed of single-layer, unicellular  endothelial cells, which are surrounded by 
a very thin basement membrane on the outside of the capillary (32). Although it 
isn’t necessarily continuous like arteriolar smooth muscle, capillaries also have 
perivascular cells that surround the endothelium, but do not contain smooth 
muscle contractile proteins like arterioles (17, 32). The total thickness of the 
capillary wall is only about 0.5 µm. The internal diameter of a capillary is 4 to 9 
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micrometers, barely large enough for red blood cells and white blood cells to 
squeeze through (17, 32). Therefore, water, cell nutrients, and cell waste can all 
interchange quickly and easily between the tissues and the circulating blood. 
Diffusion is the most common way that substances are transferred between the 
interstitial fluid. If a substance is lipid soluble, like oxygen and carbon dioxide, in 
specialized microcirculations, such as the liver and kidney, it can diffuse directly 
through the cell membranes of the capillary without having to go through the 
pores. This process is much faster than for substances like sodium ions and 
glucose that are lipid-insoluble and must diffuse through the inter-cellular 
junctions or endothelial transport proteins (10, 17, 35). The human body has 
about 10 billion capillaries with a total surface area estimated to be around 500 to 
700 m2 with a total cross-sectional area of 2500 cm2, while the total cross-
sectional area of the aorta is only 2.5 cm2 (3, 17, 24). This is why branching plays 
such a crucial role in efficient blood delivery; it allows the body to effectively 
deliver crucial nutrients and expel harmful waste over a large area from a small 
initial cross-sectional area.   
 
Dysfunction in the Circulatory System 
Peripheral Artery Disease 
Ischemic vascular diseases are the most common cause of death in the 
western world (19). The vascular endothelium is sensitive to changes in physical 
forces (e.g. shear) or signaling molecules, both of which can result in pathology 
(24).  
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Peripheral arterial disease (PAD) is an obstructive arterial disease that 
causes ischemia in the lower extremities during exercise or, in more severe 
cases, during rest (46, 50). PAD is a highly prevalent atherosclerotic disease, 
most common in aged populations (20, 46, 50), affecting 8 to 12 million 
Americans. PAD is associated with significant morbidity and mortality (20, 50), 
mostly due to a significant increase in coronary artery disease in these patients. 
PAD can be categorized as either intermittent claudication, which involves pain 
during physical activity, or critical limb ischemia, which involves a severe 
blockage in the arteries of the lower extremities that results in pain at rest (20, 46, 
50). Complications can include chronic ulcerations in the legs and feet and if left 
untreated, the complications of critical limb ischemia will result in amputation of 
the affected limb (Figure 3).  
Figure 3 – Chronic limb ischemia. Adapted from (22). 
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The pathogenesis of PAD is due to atherosclerosis (17, 20, 32, 37, 46, 50). 
Atherosclerosis is a disease of the medium and larger sized arteries in which 
fatty lesions called atheromatous plaques develop on the endothelial surfaces of 
the arterial wall (17, 32). Endothelial dysfunction is a precursor to atherosclerosis 
and can be measured before plaques form. Endothelial dysfunction involves the 
increased expression of adhesion molecules and a decrease in nitric oxide and 
prostacyclin that normally prevent adhesion of platelets and monocytes (2, 17, 
41). Circulating monocytes and lipids then aggregate at the site of the intimal 
injury; eventually the monocytes extravasate and differentiate into macrophages 
that phagocytose oxidized lipoproteins that have accumulated in the subintimal 
space (2, 41). Ingestion of the lipoproteins by macrophages will lead to a fatty 
streak and with time the fatty streak will grow larger and larger, which will cause 
the surrounding smooth muscle and fibrous tissues to proliferate to form plaques 
(2, 17). In addition, macrophages also release inflammatory cytokines that 
stimulate smooth muscle cell proliferation and expansion of fibrous tissue in the 
subintimal space (2, 41). The cellular proliferation coupled with the lipid deposits 
can become so large that the plaque bulges into the lumen of the artery and 
reduces blood flow; severe cases will completely occlude the vessel (17). 
Normally, arteries are very elastic, but eventually atherosclerosis causes arteries 
to become stiff, referred to as “hardening of the arteries,” due to connective 
tissue accumulation and calcium salts precipitating with cholesterol and other 
lipids causing hard calcifications (17). Once the arteries have hardened, the 
plaques they contain are at risk for rupture; their rough surface also protrudes 
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into the flowing blood, causing blood clots to develop that block the flow in the 
artery (17, 32, 41). Patients with PAD have a much higher risk of coronary heart 
disease; therefore the treatments aim to decrease cardiovascular risk while also 
restoring the patient’s quality of life by reestablishing blood flow to the ischemic 
limb (20, 46).  
 
Patient Treatment 
Most of the treatments for PAD are designed as secondary prevention for 
cardiovascular risk. These treatments include: supervised exercise, smoking 
cessation treatments for patients that are smokers, antiplatelet therapies, blood 
glucose control for patients with diabetes, and lipid-lowering agents (20, 37, 46). 
Other more serious treatments that address primary risk include percutaneous 
coronary re-vascularizing interventions, coronary bypass surgeries, 
endarterectomies, peripheral stenting and by-passing. In 1999, in the US alone, 
there were 1.1million percutaneous coronary revascularizations, 355,000 
coronary bypass surgeries and 131,000 endarterectomies (19). These serious 
treatments have their limitations and risks, for example, not all patients with 
coronary and peripheral vascular disease are able to receive these therapies due 
to age or unavailability of a vessel for a bypass. Also, about one third of patients 
will develop restenosis after treatment, and the neurological risk for patients that 
need to be placed on cardiopulmonary bypass for their surgery is high (19). 
While all of these treatments are somewhat successful they fail to stimulate the 
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vasculature’s natural repair process of arteriogenesis and angiogenesis to 
restore blood flow to the ischemic limb.  
Therapeutic angiogenesis and therapeutic arteriogenesis were proposed 
as treatment strategies in the early 1990s as an alternative to surgical or 
endovascular revascularization therapies. The goal of therapeutic 
angiogenesis/arteriogenesis is to treat ischemic disease by stimulating the 
natural revascularization processes of the body. This would cause a restoration 
of blood flow to an occluded tissue, which is an important but challenging goal as 
there are several hemodynamic, metabolic as well as cellular and molecular 
signaling factors involved in the mechanisms of structural remodeling and 
adaptation in the microcirculation (24, 29, 30). The ultimate goal is to understand 
the mechanisms of vascular growth in order to develop treatments to stimulate 
arteriogenesis and angiogenesis as a single therapy or even as an addition to 
other surgical procedures to achieve a more complete level of revascularization 
for both macrovascular and microvascular diseases. 
 
Vascular Growth  
There are many different aspects to vascular growth, which can be 
separated into three categories: vasculogenesis, angiogenesis and 
arteriogenesis. Each of these aspects can then be broken down further into 
different entities with different mechanisms, which will be discussed later. 
Understanding each of these aspects is crucial for developing tests and testing 
strategies that help create efficacious treatments.  
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Angiogenesis 
Angiogenesis is defined as the growth and development of new capillaries 
from existing capillaries and is a normal process critical to development, wound 
healing, reproduction, and exercise adaptation (3, 12, 15, 19, 24, 38, 51). It is 
also involved in inflammatory diseases such as rheumatoid arthritis, psoriasis, 
and tumor growth (19). Angiogenesis is categorized by two different types of 
vessel growth: sprouting angiogenesis and intussusceptive angiogenesis (12, 40). 
In the embryo, the vascular system begins with vasculogenesis, the de novo 
creation of capillaries by endothelial and perivascular cells. Vasculogenesis 
(Figure 4A) is followed by a sprouting phase (Figure 4B) characterized by the 
appearance of multiple capillary sprouts that then fuse to form the primary 
capillary plexus (Figure 4C) that is remodeled into an optimal circulation by 
intussusception (12, 13, 24, 40). In the adult, sprouting angiogenesis occurs 
primarily in response to hypoxia while intussusception is stimulated by increased 
shear stress (12, 13, 18, 40).  
Intussusceptive angiogenesis involves the formation of new capillaries by 
the development of tissue pillars in the capillary lumen and expansion of those 
lumens to form new capillary networks (12, 38, 51). Further, both vascular growth 
and remodeling occur mostly by intussusception (12, 13). The distinguishing 
factor that separates sprouting angiogenesis and intussusceptive angiogenesis is 
the formation of a tissue pillar into the vascular lumen. There are four 
consecutive steps in pillar formation: first, a zone contact is established between 
opposite capillary walls; second, there is a reorganization of the inter-endothelial 
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cell junctions and central perforation of the bilayer; the third step is the formation 
of the interstitial pillar core; and the final step is the increase in girth of the pillar 
(3, 12). Intussusceptive angiogenesis is pervasive and can occur in many organs 
during normal  (cerebral vascularization after stroke) and pathological (tumor 
angiogenesis) microvascular growth in order to establish normal branching 
patterns (12, 38). 
 Once the pillar formation has occurred there are three distinct elements 
that define intussusceptive angiogenesis. The first is intussusceptive 
microvascular growth, which can be described as the expansion of the capillary 
plexus (12). The next element is intussusceptive arborization, which is the 
formation of a vascular feeding tree. The original capillary plexus formed by 
vasculogenesis and sprouting doesn’t resemble a tree-like branching pattern, 
where larger arteries branch into progressively smaller and smaller diameter 
conduits, which is the most efficient flow delivery scheme. Intussusceptive 
arborization is the process by which the capillary plexus is transformed into a 
tree-like branching pattern after intussusceptive microvascular growth has taken 
place. Intussusceptive arborization is initiated by the formation of compacted 
vertical pillars; these pillars undergo reshaping into narrow tissue septa that 
progressively fuse to delineate a new vascular entity (12).The final element is 
intussusceptive branching remodeling, which is how the vascular tree geometry 
is optimized (13). The function of intussusceptive branching remodeling is to 
optimize hierarchy and flow properties within the system by minimizing power 
consumption and maintaining a constant shear stress, this occurs by changes in 
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branch angle through the formation of transluminal pillars near bifurcation sites of 
arteries and veins (13). Another aspect of intussusceptive branch remodeling is 
the removal of branches that are unnecessary by a mechanism called vascular 
pruning, or regression (38), where large numbers of smaller vessels are reduced 
for few larger sized ones (Figure 4D) (4, 12, 13). The cause of pruning can be 
attributed to hyperoxia, which causes VEGF to be down-regulated and 
unnecessary vessels to be pruned (38). 
D 
B 
C 
Figure 4 – Diagram of optimal circulation through angiogenesis.  A) 
Vasculogenesis is the creation of capillaries by endothelial and perivascular 
cells. B) Sprouting marks the appearance of multiple capillary sprouts that then 
fuse to form the C) primary capillary plexus. Intussusceptive angiogenesis then 
begins with intussusceptive microvascular growth (IMG), or the rapid 
expansion of the capillary plexus. Next, intussusceptive arborization (IAR) 
forms the vascular feeding tree. Finally, intussusceptive branching remodeling 
(IBR) optimizes branching geometry through branch angle adjustments and D) 
pruning. 
A 
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 The effectiveness of pillar formation is dependent on blood flow rate, and 
the faster the blood flow rate is, the faster the pillar will form, and it is a process 
that occurs with minimal amounts of endothelial cell proliferation, while also 
maintaining low vascular permeability. In contrast, sprouting angiogenesis is a 
drawn out process that requires extensive proliferation of endothelial cells and an 
increased vascular permeability , which expends more energy (12). 
 
Arteriogenesis 
Angiogenesis is the formation of new capillaries by sprouting and 
intussusception from pre-existing architecture, and vasculogenesis is the 
embryonic development of blood vessels from angioblasts (4). Arteriogenesis, on 
the other hand, is a different process by which a small arteriole chronically 
increases its diameter through outward remodeling (4, 38). Angiogenesis and 
arteriogenesis have different initial pathways as well as different results; the main 
difference is that arteriogenesis is more effective than angiogenesis in replacing 
an occluded artery by returning normal blood flow to an ischemic tissue (4). The 
outward remodeling occurs through endothelial cell activation, vascular cell 
proliferation, and rearrangement of the extracellular matrix (38).  
Increased sheer stress is a trigger for increases in arterial diameter (flow 
induced dilation), and with the change in flow that persists, outward remodeling 
of the arterial wall will occur to normalize hemodynamic shear stress (4, 19, 38). 
It makes sense then, that the maximal arteriogenesis occurs in situations at 
maximal sheer stress (4). The increased flow increases the arterial wall tension 
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and activates the endothelium (4). What is still unclear is how the increase of 
sheer stress is being “sensed” by the cells of the vascular wall (4, 19). The 
endothelium play a crucial role in the remodeling response to sheer stress as the 
first sign of arteriogenesis after arterial occlusion is that the endothelial cells of 
collateral vessels appear swollen and are randomly oriented and do not line up in 
the direction of blood flow (4). Endothelial cells are able to react to different sheer 
stress gradients by activating multiple transcription factors (19). Once the 
endothelium is activated, there is an increase in endothelial nitric oxide (NO) 
synthase, monocyte chemoattractant protein (MCP-1), transforming growth factor 
beta (TGF-β), as well as intercellular adhesion molecule-1 (ICAM-1) and vascular 
cell adhesion molecule (VCAM) (4, 19, 43). The up-regulation of MCP-1 seems 
to be important for the attraction of monocytes to the endothelium and their 
aggregation around growing collateral vessels (4, 19). The effects of NO are not 
yet understood, but it has been found to dilate collateral vessels, which 
decreases shear stress. NO can also activate metalloproteinases (MMPs) and 
may play a role in cell migration and proliferation, on the other hand, NO can also 
have inhibitory effects on endothelial, vascular smooth muscle cells (VSMC), 
atherogenesis, and inflammation (19). There is also an increased permeability of 
the endothelium, as can be seen from the adherence of monocytes, and leakage 
of platelets, plasma proteins and erythrocytes (4, 42). Other molecules that have 
been found to be involved are MMP-2, FAK, and bone marrow tyrosine kinase (4), 
which are involved in cell proliferation and migration (4). 
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Increased shear stress also changes VSMC during arteriogenesis by 
converting smooth muscle cells (SMC) between contractile (physiological 
phenotype) and synthetic (proliferative phenotype) (4, 47). The cellular signals to 
mobilize the SMC come from the degradation of the basement membrane, and 
the internal and external elastic laminas, which act as barriers to prevent outward 
remodeling of the vessel. In order for this degradation to occur MMP-2 and MMP-
9 are up-regulated in the SMC, which causes the basement membrane and the 
internal and external elastic laminas to become fragmented to allow for collateral 
vessel growth (4). Other signals come from transcriptional regulators like ERK 
and FAK, which promote cellular migration (4). The mechanical strain from the 
occlusion, increased sheer stress and growth factor stimulation lead to the 
autophosphorylation of FAK and ERK to promote the migration and proliferation 
of VSMC  so that arterioles’ successfully transform into collateral vessels (Figure 
5) (4).  
Figure 5 – The process of arteriogenesis. Adapted from (38). 
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It is important to appreciate that arteriogenesis is more effective than 
angiogenesis in replacing an occluded artery by returning normal blood flow to an 
ischemic tissue (4) and understanding the entire process is crucial to advancing 
the field of therapeutic arteriogenesis for diseases like PAD.   
 
Conclusion of Vascular Growth 
All of the remodeling processes are a result of complex and coordinated 
cellular interactions that are brought about by cell-to-cell and cell-to-matrix 
communication from environmental stimuli, so that constant blood vessel 
remodeling occurs (38), where network structure is remodeled to match tissue 
requirements . Understanding how vascular growth works and how different 
therapies affect the long-term stability and survival of tissue in patients with 
ischemic diseases is critical to designing both revascularization therapies for 
ischemic disease (and anti-angiogenic therapies for cancer) (38, 51). As we 
progress in therapeutic arteriogenesis and angiogenesis there are important 
considerations that need to be made: delivery methods and agents need to be 
effective in stimulating arteriogenesis but also have acceptable levels of risk, e.g. 
plaque instability, plaque growth, or an inflammatory response. We must weigh 
success from our vascular growth treatments with treatment failure from tumor 
growth or other inflammatory diseases, and decide how much of that risk is 
acceptable when searching for success (19). As we move forward and continue 
to gain insight into vascular growth and the role that it plays in other diseases, 
there is the potential that this type or research could change the face of medicine 
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in the next decades, with more than 500 million people worldwide predicted to 
benefit from pro or anti-angiogenesis treatments (15). 
 
Attempts to Stimulate and Assess Vascular Growth 
It is important in the development of treatments that we are able to both 
stimulate and assess vascular growth.  With this goal come many challenges as 
we make progress toward developing vessel maturation therapies for therapeutic 
angiogenesis.  One hope for patients who are suffering with various ischemic 
diseases is the ability to form vascular networks in vivo by delivering angiogenic 
or arteriogenic molecules as recombinant proteins using controlled-release 
devices or as genes using viral vectors or plasmid DNA (23). Results from clinical 
trials using these techniques have shown that the formation of a mature vascular 
network will require very precise regulation of a large number of both angiogenic 
stimulators and inhibitors (24). For example, clinical trials for limb ischemia using  
VEGF and FGF yielded less than optimal results, as some patients had 
successful limb salvage while a majority of the patients treated with VEGF 
developed transient limb edema, which is consistent with VEGF enhancement of 
vascular permeability (1). Preclinical experiments using a controlled release 
device or an adenoviral vector to deliver basic FGF or VEGF led to the transient 
development of stable vascular networks, which after time began to resemble an 
immature tumor vasculature (11, 36). Therefore, more precise understanding of 
the vascular growth process through the use of animal models is necessary 
before therapeutic angiogenesis will be successful. 
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Many follow up experiments have focused on a more precise approach as 
the lack of positive trial data has focused researchers and clinicians on the fact 
that arteriogenesis and angiogenesis are complex processes and simply 
supplying vascular growth factors to ischemic tissue does not provide effective 
therapy (49).  
One approach to improve the effectiveness of therapeutic angiogenesis is 
to deliver a cocktail of angiogenic molecules to the desired site in a 
spatiotemporal manner that more accurately resembles their endogenous 
production (24). Polymeric delivery systems can mimic the endogenous release 
of two or more growth factors. For example, controlling the dose and rate of 
delivery for a VEGF and platelet-derived growth factor (PDGF) combination 
therapy leads to vessels that appear more mature than those formed using 
VEGF alone (39). These results moved researchers to find out the minimal 
number and type of molecules needed to produce stable vascular expansion and 
to figure out how to optimize delivery in order to effectively treat ischemic disease. 
Another approach is to deliver a transcription or growth factor that regulates 
expression of the various growth factors required for mature vessel formation. 
Hypoxia-inducible factor (HIF)-1α is responsible for regulating the expression of a 
large number of pro- and antiangiogenic genes and it enhanced perfusion in an 
ischemic rabbit hind-limb model (45, 48). 
To be truly effective, once mature vessels have been established, 
therapeutic angiogenesis must successfully create a mature network structure. A 
mature network involves network remodeling and vascular reactivity. Network 
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remodeling involves arborization and pruning to create an efficient network (12, 
31), while vascular reactivity is important for regulating blood flow in response to 
tissue needs (26). The ultimate goal of therapeutic angiogenesis is to 
revascularize ischemic tissue, which requires a mature vasculature and a mature 
network that will restore tissue oxygenation levels in response to the chronically 
insufficient blood supply. 
The therapies described above are moving towards creating more mature 
vessels but little work is being done to create more mature networks, which is 
due to the difficulty of assessing a network. Most often, network maturation is 
assessed by counting vessels in a histological cross section, which gives little 
information on what the overall network looks like. In order to create more 
effective therapies it’s important to understand how to create more mature 
networks.  
Several morphological parameters such as the diameters of blood vessels, 
blood path length, vessel length, branching characteristics, and vessel quantity 
within a vascular network describe the architecture of the microcirculation. 
Following ischemia, these morphological parameters change. Diameters 
increase in response to the elevated shear stress, blood path length increases as 
blood is re-routed, which consequently causes a change in the branching 
characteristics of the network because of the structural remodeling and changes 
in flow direction. All of these changes could be important when developing 
therapies; however, researchers in this area typically ignore network topology. 
Instead of focusing on one morphological parameter, such as vessel number, it 
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would be beneficial to examine as many as possible in order to evaluate the 
vascular network as a whole. The microcirculation is critical to nutrient and waste 
exchange and changes could affect muscle functionality; the overall goal of this 
research was the changes in morphological parameters following arterial 
occlusion.   
 
Objectives/Hypothesis 
 Currently, our lab uses a manual process to gather morphological data for 
our experiments. The morphological data is used in a model to predict 
hemodynamics and calculate vascular morphometry in normal and remodeled 
microcirculatory networks. This study aims to establish a system that will 
expedite the process of gathering morphological data needed for the model and 
to examine the impact of arterial occlusion on morphology. More specifically, this 
study had three distinct objectives to reach the goal: 
(1) Create a vascular casting protocol to only cast the arterial side of the 
microcirculation. Previous work filled both the arterial and venous sides, 
even though only the arterial side was measured. The venous fill 
increased the difficulty of measurement and tracing and provided no 
additional value to the research. 
(2) Decrease the amount of time it takes to measure the microvasculature of 
the anterior gracilis muscle through some form of automation. Previous 
work used completely manual measurements to gather data and I sought 
to expedite this data-gathering process.  
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(3) Determine the effects of elevated flow in a collateral artery on branching 
arteriolar network topology. This aim utilizes the proposed methods to 
demonstrate proof-of-concept and to determine if collateral remodeling 
was associated with remodeling in the arteriolar side branch trees.  
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Chapter 2 – Development of an Arterial-Specific Vascular Casting 
Procedure 
Introduction 
Efficient morphological assessment requires a multi-step tissue 
preparation process in order to collect data for analysis and for input into our 
model. The process of sample preparation can be summarized in 5 steps: 
vascular casting, dissection, dehydration, clearance, and sample mounting. 
Improving the vascular casting protocol could optimize the entire process of 
gathering data for the model.  The goal of vascular casting is to fill the circulation 
with a high contrast agent, which generally requires clearing the circulation of 
blood. The original protocol for vascular casting utilized nontoxic India ink(16).  
Although this protocol is successful in achieving high contrast between the 
vasculature and surrounding tissue, there are some drawbacks to casting with 
India ink and the subsequent morphological analysis, which include: India ink 
remains in a liquid state, so leakage occurs if the vessels aren’t cauterized 
properly during muscle dissection; India ink takes a significant amount of time to 
dialyze, filter, and purify in preparation for injection; and India ink casts both the 
arterial and venous side of the circulation. I aimed to resolve these three issues 
to improve data collection. The solutions formulated for visualizing only the 
arterial side were to increase the viscosity of the casting agent to prevent it from 
traversing the capillary level by adding dextran to the casting compound or to use 
a fluorescent marker to label the arterial side of the circulation, so that when 
imaged the arterial side is expressed with fluorescence. While researching 
23 
 
different casting agents, I found a group that was able to successfully cast the 
spinotrapezius vasculature of a rat using Microfil (27). Further research into 
Microfil demonstrated that it was a radiopaque, polymerizing silicone rubber 
compound with variable viscosities that could be used to cast the arterial side of 
both a rat and mouse kidney (33). This previous work was successful using 
Microfil to cast the arterial side and led me to begin protocol modification with 
Microfil instead of modifying the India ink or using fluorescence.  
 
Materials and Methods 
 Microfil is a casting agent with variable viscosity, composed of a colored 
compound, diluent, and curing agent. The optimal Microfil viscosity for arterial 
casting of the gracilis muscle was investigated using a murine model. All 
protocols were approved by the Institutional Animal Care and use Committee. 
Male Swiss Webster mice weighing 25-35g from the California Polytechnic State 
University Vivarium were used to optimize the Microfil casting protocol, 8 male 
C57BL/6 mice were used to validate the consistency of the protocol, and another 
8 male C57BL/6 mice were used to assess the impact of arterial ligation on 
microvascular morphology (presented in Chapter 4).  
The longitudinal gracilis arcade is the main blood supply for the gracilis 
muscle, and is fed by the profunda femoris of the femoral artery (medial side) 
and the saphenous artery (lateral side) (16). The gracilis arcade runs parallel to 
the muscle fibers over almost the entire length of the muscle (16) (Figure 6).   
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Completing a vascular cast with Microfil requires the preparation of 
surgical instruments and materials. These included forceps, bone-cutting 
scissors, iris scissors, hemostats, microdissection scissors, a vascular clamp, 
surgical tape, 20ml syringe, bench cover, heating pad, catheter/stopcock/blunt 
needle apparatus containing a PE-100 catheter, isoflurane anesthetic, and gauze 
sponges (Figure 7). A vasodilator cocktail is also necessary to flush out the 
blood and maximally dilate the vasculature before injecting the casting agent. 
Figure 6 – The gracilis artery runs through the gracilis anterior 
and is fed by the profunda femoris and the saphenous artery. 
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The cocktail consists of heparin, adenosine and sodium nitroprusside, which are 
all combined with PBS solution and heated to 37°C in a water bath. The Microfil 
mixture is created by vortexing 2mL MV-122, 1.25mL HV-Diluent and 1.25mL 
MV-Diluent into a 14mL conical and placing in the 37°C water bath (Figure 8A). 
Once the prep work was done the animal was weighed and anesthetized with 
isoflurane and laid supine upon a heating pad to maintain core body temperature. 
Hindlimb hair was removed with clippers and depilatory cream (Figure 8B). The 
Figure 7 – Microfil casting procedure set up. A) Light microscope, which can be 
rotated in to check on the progress of the vascular cast. B) Surgical instruments – 
Hemostats (1), Bone scissors (1), metzenbaum scissors (1), Iris scissors (1), forceps 
(2), microdissection scissors (1), vascular clamp (1). C) Syringe pump. D) Bench 
Cover with heating pad underneath. E) Octopus light source. F) Isoflurane nose cone. 
G) PE-100 catheter. H) Miscellaneous items-Saline, gauze, tape.  
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animal was taped down to the heated bench cover and the skin was separated 
from the superficial abdominal and thoracic musculature. Once the skin was 
removed, the 20mL syringe was filled with warm vasodilator cocktail, loaded into 
the syringe pump, and attached to the catheter. An incision was made through 
the abdomen, close to the diaphragm before the ribs and diaphragm were quickly 
transected and reflected with hemostats to expose the chest cavity (Figure 8E). 
Due to pneumothorax, the ventricular catheterization must be done quickly 
before blood begins clotting, which would ruin the clearance and vascular cast. 
Excess tissue was cut away from around the heart and a small incision was 
made in the apex of the left ventricle. The catheter was inserted through the 
incision into the left ventricle and clamped in place with a vascular clamp (Figure 
8C). Once the catheter was in place the right atrium was cut and the syringe 
pump was started in order to inject the vasodilator cocktail at 5ml·min-1. The skin 
above the gracilis muscle was removed to visualize vascular clearance before 
refilling the 20mL syringe to continue flushing the vasculature (Figure 8G). Once 
the entire vasodilator cocktail had been injected, .2mL of curing agent was added 
to the Microfil mixture to start the polymerizing reaction (it is crucial to wait until 
the last possible moment to add the curing agent when preparing the Microfil 
mixture to maintain the compound in a liquid state during perfusion). The Microfil 
mixture was inserted into the syringe pump and perfused at .5mL per minute 
(Figure 8D). The hindlimb was monitored under the microscope until the Microfil 
had passed the knee. At this point the syringe pump was stopped (approximately 
1mL of Microfil had been perfused) and a tourniquet was tied around both ankles 
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with silk suture to prevent entry of the Microfil in the venous circulation through A-
V shunts near the ankle (Figure 8F). The Microfil perfusion was resumed, and 
continued until the casting agent spilled out of the right atrium or until the cast 
was deemed satisfactory by visual inspecting the gracilis under the microscope. 
The catheter was removed, but the heart clamp was left to prevent any Microfil 
leakage, and the mouse was allowed to sit undisturbed for at least 10 minutes 
while the Microfil begin curing (Figure 8H). The open wounds were covered with 
plastic wrap and the mouse was placed in a plastic bag to prevent desiccation 
while the animal was left overnight at room temperature to allow the Microfil to 
cure completely (Appendix B).  
Following the overnight curing period, the gracilis muscles from both limbs 
were carefully dissected and gently placed between two cover slips to maintain in 
situ orientation during the dehydration process. The muscles were dehydrated by 
a graded series of ethanol solutions (25, 50, 75, 95 and 100%) for at least 12 
hours for each alcohol dilution. Following dehydration the muscles were placed 
into 100% methyl salicylate for clearance (16). Once cleared, the muscle was 
oriented correctly, placed onto a slide, covered with permount, coversliped, and 
given 48 hours to dry before imaging. See Chapter 4 materials and methods for 
imaging.  
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Figure 8 – A) Microfil cast ingredients (from left to right) MV-Diluent, HV-Diluent, 
MV-112, Curing agent. B) In order to prep the animal the hindlimbs were trimmed 
with clippers and then the hair was removed completely with depilatory cream to 
minimize hair contamination in the sample. C) An incision was cut in the apex of the 
heart and PE-100 catheter tubing was inserted into the apex and clamped into place 
with a vascular clamp. D) Following clearance the 20mL syringe was loaded with the 
Microfil cocktail for perfusion. E) In order to gain access to the heart the ribs and 
diaphragm were quickly cut through and clamped back with hemostats in order to 
open the chest cavity. F) Ankle ligation to prevent Microfil from casting the venous 
side through A-V shunts. G) Proper clearance of the gracilis muscle was checked 
before Microfil was perfused. H) After Microfil perfusion gracilis was checked to 
make sure perfusion penetration was adequate and that there was no venous  
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Results 
  
 Achieving the desired results required two different studies with multiple 
experiments. Preliminary testing of the Microfil yielded poor results (Figure 9). 
Further experimentation adjusting the viscosities by varying the amount of MV-
122 and HV-Diluent (Table 1 – Study 1) also provided poor results (Figure 10). 
For study 2, the ratios of diluent and MV-122 were kept at a constant 5:4 ratio, 
Figure 9 – Preliminary Microfil yielded poor results as the 
filling is incomplete and spotty. This sample is of the right 
anterior near the saphenous artery. 
Table 1 – Studies with Microfil casting compound ratios. Study 1 was 
unsuccessful as adjusting the ratios between the MV-122 and Diluent 
ruins the compound. Study 2 was successful; it maintains the 5:4 ratio of 
Diluent to MV-122 while also varying the viscosity. Ultimately, 
experiment 2 of study 2 provided the wanted results. 
   Study 2 
   Study 1 
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while the viscosity was adjusted by mixing MV-diluent with HV-Diluent (Table 1 – 
Study 2). Experiment 2 provided the desired results: solid casting with no 
bubbles, which only penetrated to the capillary level (Figure 11).  
 
 
Figure 10 – A) Poor results from the left anterior of study 1-experiment 1 near 
the saphenous artery. B) Poor results from the left anterior of study 1-
experiment 5 in the center of the gracilis muscle. 
Figure 11 – Control animal B. A) Left leg anterior gracilis. B) Right leg 
anterior gracilis. 
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Discussion   
 Results from the new Microfil casting procedure were a great improvement 
over previous India ink vascular casts. Figure 12 displays a successful India ink 
fill of the anterior gracilis. From Figure 12, it is clear that both the arterial and 
venous side of the circulation is filled. The India ink completely fills the arterial 
side, the capillaries (which look like strands of hair in the image) and then the 
venous side. In order to use this sample for measurement one must visually 
isolate the arterial side from the venous side before proceeding. The interest for 
our lab lies in the arterial side of the circulation because that’s where blood flow 
is determined and where vascular remodeling predominantly occurs following an 
occlusion (19); the venous side cast just adds confusion during morphology 
measurement. Although it is possible to discern arterial from venous by looking at 
Figure 12 – A successful India ink fill casts both the arterial 
and venous side of the vascular system.  
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relative size of the vessels (the venous side is larger than the arterial side) 
mistakes are still made and often smaller arterial trees are missed due to the 
complexity of the images. Arteries and veins run parallel to each other and 
intertwine along their paths, causing difficulties when trying to differentiate 
between the two. The whole process would be easier if the vascular side wasn’t 
casted. My final Microfil vascular casts (Figure 11) show that it is possible to cast 
the arterial side of the anterior gracilis using a ventricular catheterization. It is 
clear from Figure 13 that the Microfil penetrates right up to the capillaries on the 
arterial side and then stops. Further, only the arterial side of the saphenous and 
profunda femoris is filled, which indicates that no Microfil was able to transition to 
the venous side through the A-V shunts in the lower leg.  
As stated earlier, Microfil is a polymerizing silicone rubber compound that 
comes in three parts that must be mixed to create the injectable compound. This 
Figure 13 – Magnification of Figure 11A to show penetration of Microfil at 
capillary level. 
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eliminates the other issues encountered with India ink as once Microfil has cured, 
it will not leak and the preparation involved is more straight-forward, requiring 
only mixing without the need to dialyze, filter, and purify (Table 2). All of the 
control Microfil samples can be found in Appendix A. It is important to note that 
although the same protocol was followed for every vascular cast, there are still 
variable results in the samples. This is likely due to the variability of catheter 
placement into the apex of the left ventricle during the ventricular catheterization. 
There is a very limited window of time to correctly cut the apex of the heart and 
clamp the catheter in place. If it is placed incorrectly it is difficult to shut off the 
syringe pump and reposition the catheter without damaging the tissue. There is 
also a risk of blood clotting, which will impede blood clearance and penetration of 
the casting agent into all arterial branches of the vasculature. Poor catheter 
position, damaged heart tissue, and blood clotting can all be factors that 
determine a good cast from a poor cast (Appendix A – replicate A versus 
replicate B).  
To develop the Microfil casting protocol I began with a 4:5 ratio of Microfil 
MV-122 and HV-Diluent (Figure 8A), which was then catalyzed with 5% by 
volume of the curing agent. These values were taken from the Microfil manual 
Table 2 – Tabular comparison of Microfil versus India ink 
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and also used by Lash and Marxen in their research groups (27, 33). Using these 
values I began my preliminary ventricular catheterizations and the results (Figure 
9) were poor, showing incomplete and spotty filling. The initial conclusion was 
that the poor casting was due to an error in technique with the ventricular 
catheterizations, so more India ink casts were performed to compare to previous 
results. Once correct technique was established, more Microfil casts were 
performed with similar results. Efforts were then focused on varying the flow rate 
to achieve the desired results; the idea being that if the Microfil was too viscous, 
increase the force of injection. The flow rate was raised to 5ml/min (ink fills were 
performed at 3ml/min), with more poor results; any higher rate resulted in a 
pressure build-up that would cause the syringe pump to malfunction and 
sometimes catheter ejection from the heart. The next modification was to 
decrease the viscosity of the Microfil cocktail by adding less of the HV-Diluent 
and more MV-122.  I experimented with a change in the HV-diluent to dye ratio in 
order to vary the viscosities and find a mixture that would allow for maximum 
penetration while also preventing venous return (Table 1); however, this 
approach yielded poor results, (Figure 10). The conclusion was that although the 
viscosities of the mixtures were different, the ideal ratio between the mixtures 
was changing and, therefore, the Microfil was unable to mix properly when 
vortexed, which yielded poor vascular casts.  
A batch of the normal viscosity diluent—MV-Diluent, was ordered and 
used to mix with the high-viscosity diluent in a new attempt to alter the viscosity, 
while also still preserving the necessary ratios. This approach was markedly 
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more successful, which led to discovering the best mixture for maximum arterial 
penetration and minimal venous return during vascular casting (Figure 11). 
However, although the Microfil was stopping at the capillary level, it was still not 
viscous enough to be stopped at the artery level and so the Microfil would 
perfuse down into the lower leg and across the A-V shunts. This could be seen 
under the microscope as the Microfil would stop at the capillaries of the gracilis 
but would still return on the venous side of the femoral and saphenous arteries, 
causing backfill into the venous circulation of the gracilis. The solution to this 
problem was to tie a tourniquet around the ankle of the mouse to prevent the 
Microfil from entering the a-v shunt (Figure 8F). This was successful, with slight 
modification. Initially the tourniquets were tied after the vasodilator cocktail but 
before the Microfil, which caused a build-up of fluid pressure in the lower leg. 
This pressure build-up led to a reversal of the pressure gradient when the syringe 
pump was stopped and caused the Microfil to be pushed back and un-fill the 
artery. This problem was addressed by starting the Microfil casting with no 
tourniquet on the ankle and applying the tourniquet a few second after the 
Microfil passed the tourniquet site on the ankle. At this point the Microfil flow rate 
had been lowered to .5ml per minute. This decrease allowed for easier 
visualization under the microscope as well as providing ample time to perform 
the tourniquets.  
Multiple variations of Microfil were tested before the ideal viscosity 
(keeping the ratio between diluent and MV-122 constant) was found. Even then, 
protocol adjustments needed to be made to accommodate the venous filling from 
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the a-v shunts. It is also important to note that the India ink casting protocol 
perfused 5ml of ink, even though a mouse only has ~2ml of blood volume. I had 
much better results when setting the pump to only deliver 1ml and visually 
inspecting the casting progress in the gracilis muscle. If the cast was complete, 
the Microfil perfusion was stopped. If the cast was incomplete, the pump was 
continued until adequate casting had been achieved. Performing vascular casts 
with Microfil was successful and future work in this area could test varying the 
ratios of the different diluents depending on the research needed. The new 
protocol calls for a 50/50 mixture of high-viscosity and normal viscosity diluent for 
the results shown. However, if further penetration of the capillaries or less 
penetration of the arterioles was desired, a lower or higher viscosity Microfil 
cocktail may be necessary, respectively.  
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Chapter 3 – Development of an Image Morphometry Macro 
Introduction 
 Once the casted tissue is prepared (chapter 1) and imaged (chapter 4), 
morphological analysis is necessary. Important morphological parameters 
include: vessel length, vessel diameter, branch angle, vessel order, and vessel 
quantity. To manually measure these features is a laborious task; this entire 
project consisted of 32 samples requiring morphological analysis, with the 
samples averaging around 1000 vessels per sample (Appendix H). The first step 
in the morphological analysis is to order each vessel in each sample, followed by 
each morphological measurement. So, to obtain data on length, diameter, and 
branch angle requires 96,000 measurements, plus the time it takes to order each 
sample. The other issue with manual measurement is the variability in human 
measurement. Any type of automation or efficiency brought to this process that 
could decrease time and/or increase the consistency with measurement would 
be beneficial.   
The general challenge with automatic determinations of vessel 
architecture is determining “vessel” from “non-vessel”. An algorithm needs to be 
written and “trained” with numerous samples. Then the vascular system can be 
broken up into individual segments and functions can be written to consistently 
measure the different morphology.  
Two areas where automatic measurement and image analysis are being 
pursued are ophthalmology and neuroscience—where the morphology of retinal 
blood vessels and neuron axons, respectively, are important (5, 8). Interest in 
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measuring retinal vessel architecture stems from the fact that it is non-invasive 
and has been correlated with cardiovascular and cerebrovascular disease (8, 28). 
Retinal vessel measurement faces similar issues as our lab with manual 
quantification and measurements being slow and biased by the observer (8). 
Algorithms can be used to automatically determine arteriolar diameters (8) by 
fitting a vessel intensity profile to a double Gaussain function by non-linear 
regression, and using an edge detection algorithm. This model, created by Sobel, 
involves using a sliding linear regression filter to determine points of maximum 
intensity variation to determine “vessel” from “non-vessel” (8).  Sophisticated 
algorithms require many samples to be tested in order to become more precise 
with each iteration. Chapman’s group found that even their most consistent and 
repeatable algorithms yielded measurements significantly greater than manual 
measurements (8). Even though the results between automatic and manual were 
different, there is still value in the consistency with which an automated program 
can make measurements. Ideally, a full automation strategy would be designed 
to acquire the necessary morphology measurements, however, due to the skillset 
and amount of samples necessary, a different avenue from full automation was 
pursued.  
Our interest in microvascular topology requires manual measurements of 
diameter, length, branch angles, vessel order, and vessel quantity for input into a 
computational model for calculating hemodynamic conditions. Each of these 
morphology measurements must be evaluated in hundreds of vessels using 
morphometry software, such as ImageJ. This effort requires tracing thousands of 
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vessels manually, plus drawing the length and diameter of segments to obtain 
each of the morphological measurements; this process requires considerable 
time, even for those experienced with the technique—to order and measure the 
lengths and diameters of a sample would take about 2-3 hours, depending on the 
number of vessels. The goal for this portion of the research was to improve the 
efficiency of the manual tracing by developing a process to semi-automate the 
morphological analysis by combining the diameter and length measurements into 
one process instead of two.  
 
Materials and Methods 
Design Criteria 
One of the goals of this thesis was to increase the efficiency of the morphology 
measurements. One of the inefficiencies I pinpointed was in the manual data 
collection. Ideally, a fully automated data collection program would solve this 
issue. However, full automation was not only outside of my skillset, but also 
would require approximately 100 samples to distinguish “vessel” from “not-
vessel”; so instead, I opted to simplify the problem significantly. The objective for 
this aim of the thesis was to gather two diameter measurements and two length 
measurements, average the diameters and lengths independently, and record 
both the length and diameter of a vessel when the user defined the vessel with 4 
mouse clicks. This, theoretically, would save time (since the user doesn’t have to 
measure the diameter and length separately), while also being a suitable 
replacement for manual measurement by outputting similar results or even  
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increasing the accuracy of the data collected (since two diameter/length 
measurements would be averaged, instead of making one measurement).  
 
Vessel Morphometry Procedure 
The automation program was written using ImageJ and the macro editor. 
To reiterate, the goal for the program was to calculate the length and diameter of 
a vessel by drawing a quadrilateral to approximate the shape of the vessel 
segment (Figure 14). This is accomplished with four user-defined points, which 
create the quadrilateral and then output an average vessel diameter (based on 
the average of H1-3 and 2-4) and vessel length (L1-2 and 3-4) (Figure 14). To define a 
vessel, 4 points are indicated to outline the vessel by hovering the mouse over 
each point and selecting the “a” key. The points must be selected in the correct 
order or the program will output incorrect measurements. Any mistakes can be 
reversed by selecting “y” to erase the previous selections. From the 4-points, the 
Figure 14 – General idea for how the automation program would work. The user 
would click the 4 points in order to identify a given vessel; the program would 
then draw a quadrilateral and measure the length and breadth by averaging the 
distance between 1-2 and 3-4 and the average distance between 1-3 and 2-4, 
respectively. 
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macro creates a quadrilateral, whose length and height dimensions are 
automatically calculated and output into an ImageJ log file, which can be saved 
and exported into Excel (Appendix D). The code used to carry out these 
measurements can be found in Appendix C. 
 
Automation Validation 
 As a simple test to test my macro, I drew 3 rectangles (Figure 15) and 
measured them manually and with the macro in ImageJ. The results (Table 3) 
show that the macro is calibrated (calibration is built into the macro so re-
calibration for every image is unnecessary—see manual protocol in Appendix L), 
measuring correctly (Table 3) and ready to be tested with a more robust 
Figure 15 – 3 rectangles measured manually and with the macro to 
test functionality.  
Table 3 – Automation validation results 
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comparison on vascular casted samples. Next, four gracilis muscle samples were 
chosen (ECLNI, ECRNI, FCLNI and FCRNI) and were measured with the macro 
and manually to examine the accuracy of the program when measuring blood 
vessels instead of rectangles. Those four samples were chosen because they 
had the highest number of blood vessels, which would yield a more powerful 
comparison.  
 JMP was used for the statistical analysis to determine if the macro could 
substitute for manual measurement of lengths and diameters. Because there 
were multiple orders and therefore multiple measurements per sample a 
repeated measures analysis was performed; statistical significance (p<0.05) 
between each condition was assessed using the Tukey-Kramer test, and a block 
was placed on the mouse to eliminate mouse-to-mouse variability within the 
results (Appendix E).    
 
Results 
 
 The macro-obtained measurements were compared to the manually 
obtained measurements to examine if the macro could be used as an acceptable 
substitute to manual measurement.  Average lengths and diameters from 
samples ECLNI, ECRNI, FCLNI and FCRNI were used to calculate the least 
square means for each order and then the least square means were compared 
for each order. The results show no significant difference between macro and 
manual measurement except between order 5 length values (Figure 16 and 17).  
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Discussion  
The results showed that that the only significant difference between the 
macro and manual measurement came from measuring order 5 lengths. The 
reason for this difference stems from the way that the macro is estimating values. 
When a vessel is straight (Figure 14) using a quadrilateral to approximate the 
Figure 16 – Macro versus manual measurements for length showed a 
significant difference for order 5 vessels. 
Figure 17 – Macro versus Manual measurements for diameter showed no 
significant differences. 
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vessel works well and you can expect to get an accurate value for the length of 
the vessel; however, when a vessel becomes more tortuous (Figure 18), a 
quadrilateral estimation isn’t as accurate. I expected this would only be a problem 
with vessel lengths as the diameters are always a straight measurement. When 
looking at the samples it seemed as tortuosity went down the higher you went in 
vessel order, yet surprisingly, the only difference came in order 5 vessels, and I 
think the only reason for that is the sample size, which was 35 order 5 vessels. 
Since the program is measuring straight lines for curving vessels, the length 
measurements are always going to be shorter than actual measurements, but 
statistically, this only makes a difference for order 5 vessels. Therefore, if this 
program is used to substitute manual measurements, order 5 lengths should still 
be measured manually.     
The major advantage to this program is one of organization, which leads 
to efficiency. When four points are selected and a rectangle is drawn and 
Figure 18 – Using the automation tool will approximate a vessels length if it is 
curved. The program output a length of 76.52μm, while the manual measurement 
output 123.01μm, which is a 37.79% difference. 
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measured, the rectangle outlining the vessel remains as a marker for which 
vessels have been measured already (Figure 14). This doesn’t happen when 
using the manual measurement technique, so remembering which vessels have 
been measured becomes challenging. The macro also groups length and 
diameter into one measurement output, rather than manually measuring the 
length and the diameter in two different measurements.  
Conversely, one difficulty with the macro is still the time it requires to make 
a measurement. Hovering over four different points and clicking a button on a 
keyboard to define thousands of vessels still takes a lot of time. The macro is a 
step in the right direction, but there are still improvements to be made that could 
save more time. Another issue is measuring the lengths of level 5 vessels. Since 
there are a low amount of level 5 vessels per sample an easy solution is to 
switch to manual measurement. Human error is another issue, since both 
methods require a user to define a vessel; some variance will always be present. 
The percent differences seen in Table 2 demonstrate that even with simple 
samples it’s hard to define the same start and end for the manual and macro 
techniques; however, this small of a variance is unlikely to have any effect on the 
morphometry. 
The initial logic for the development of the macro required the macro to 
wait for 4 clicks from the user, sort the points, draw the correct quadrilateral, and 
then make the calculations and output. However, limited programing abilities 
required adjusting the initial logic while still obtaining the desired output. For 
example, using the “getCursorLoc” command (meant to pick points when user 
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clicked the left mouse button) was really hard to work with and picked up left and 
right clicks, click releases, and rollovers. Searching online discussion forums I 
came across the use of a “hot key” to label points instead of a mouse click; 
implementing this method eliminated the “getCursorLoc” issues, and instead of 4 
mouse clicks, required the user to hover over the point of interest and press the 
letter “a” to define a point. Problems also arose when trying to create a “sort” 
function to order input selections from the user correctly, but was solved by 
requiring the user to select their points in the following order: upper left, upper 
right, lower left, and then lower right. The input always comes in the same order 
so the calculations are performed correctly. Output was another issue; initially the 
program output the values as one single column and exporting it to excel placed 
all of the data into cell A1 instead of individual cells. Updating the code to a new 
multi-column format and adding commas after each data point so that excel 
could use them as a delimiter allowed for excel import into separate cells, in 7 
columns. Slight deviations were taken from the initial design criteria; however, 
the final macro accomplished the goal of recording length and diameter values 
with one measurement. 
This program is a good starting point to progress away from manual 
measurement but it is still relatively basic, and numerous features could be 
added to optimize morphological measurement. Currently, it gathers data from 
four clicks to output the same length and diameter measurements as the manual 
method, all things being equal. Ideally, the program would gather all of the 
desired morphological measurements. As stated earlier, an artificial intelligence 
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algorithm could solve this problem by scanning the sample and through pixel 
recognition decide whether a pixel is “vessel” or “not vessel”. This would be done 
throughout the image until the program has a data-driven image of the vascular 
system, which it would use to compute the morphology values. This level of 
automation is achievable but requires intensive knowledge of algorithm 
development in image recognition and a high number of samples to test for 
algorithm augmentation. A more feasible next step for our lab would be to 
integrate branch angle measurement into the macro. A simple addition would use 
the ImageJ angle measurement tool and mark which angles have already been 
measured. A more elegant addition would store every defined vessel as its own 
element, then the user could select two adjacent elements and the program 
would calculate the branch angle between them. 
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Chapter 4 – The Impact of Collateral Enlargement on Transverse Arteriolar 
Tree Structure 
Introduction 
After creating a successful vascular casting protocol using Microfil and a 
measurement automation program, the next step was to gather morphological 
data on a remodeled vascular network following arterial occlusion. PAD is 
caused by insufficient blood flow to a tissue, which is usually induced by 
atherosclerotic lesions that produce increased resistance and decreased blood 
flow to the distal tissue, sometimes completely occluding an artery (20, 37). PAD 
has many factors that can contribute to the pathophysiology, which is why a 
ligated model was used to replicate an arterial occlusion in order to examine the 
impact collateral enlargement has on transverse arteriolar tree structure.   
The goal of this model is to induce blood flow changes and repair 
processes that we can relate to PAD. Blood that previously flowed through the 
femoral and saphenous arteries will mainly be rerouted through the deep femoral 
and profunda femoris (34). Essentially, there are no more large arteries to feed 
the distal hindlimb following ligation; this causes an increase in flow as oxygen 
and other nutrients are rerouted through the gracilis collateral flow path to reach 
the lower limb. The downstream tissues experience hypoxia and inflammation in 
the lower leg, which promote angiogenesis (34). The ligation also causes an 
increase in wall shear stress through the collateral vessels from the elevated 
blood flow, which will result in the activation of endothelial nitric oxide synthase 
(eNOS) to produce NO to cause vasodilation (25). The immediate effects of the 
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increased shear stress will cause vasodilation due to the blood flow divergence, 
while the chronic increase of shear stress will induce arteriogenesis (4, 43, 44). 
Therefore, we can expect to see the collateral arteries that feed the gracilis 
muscle to outwardly remodel in order to provide the blood flow needed for 
recovery of the hindlimb (6, 7). The next step becomes investigating if the 
increased flow and shear stress in the collateral results in a change in the 
transverse arteriole (vessel order 4 and 5) networks branching off. This is 
important for a few reasons: the presence of collaterals is a decent indication of a 
patient with ischemic disease so stimulating arteriogenesis in these collaterals 
could be used as a therapy for PAD. However, it is unknown how arteriogenesis 
affects the microcirculation in the muscle housing the enlarged collateral and 
since the microcirculation is critical to nutrient and waste exchange, changes 
could affect muscle functionality. On one hand the increased flow could lead to 
architecture and vessel expansion, and on the other, the increase of pressure 
could lead to regression. This study could help determine if stimulating 
arteriogenesis could be a concern because of the possibility of compromised flow, 
and therefore, functionality, in the collateral-containing muscle. 
 
Materials and Methods 
Ligation Surgery  
All protocols were approved by the Institutional Animal Care and Use 
Committee. Eight C57BL/6 mice were used as the experimental group and had a 
ligation tied around their left femoral artery just distal to the profunda femoris, 
while a sham surgery was performed on their right leg. The surgeries were 
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performed under aseptic conditions and using isoflurane anesthesia. Prior to the 
procedure each animal was prepared by removing the hair over the surgical area 
with clippers and depilatory cream and then disinfecting the area with Nolvasan. 
The mice were maintained at 35±1.0°C using a rectal-temperature controlled 
heating pad. The initial incision was made on the medial aspect of the hindlimb, 
directly above the femoral neurovascular bundle, and was extended upwards to 
the abdominal wall and downwards towards the origin of the saphenous artery, 
making sure to keep the incision over the neurovascular bundle. Sterile saline 
solution was used to irrigate the tissue and prevent muscle desiccation. 
Connective tissue was blunt dissected to increase exposure. Following 
connective tissue removal the epigastric fat pad was removed by heat cautery to 
expose a site for the ligation just downstream to the profunda femoris. At the 
chosen spot for ligation the nerve was carefully blunt dissected away from the 
femoral artery, and then the vein was separated from the femoral artery in a 
similar fashion. To ligate, 6.0 silk suture was used; following ligation, the skin 
incision was closed with 7.0 polypropylene suture.  
 The sham surgery procedure included an incision above the femoral 
neurovascular bundle. Sterile saline was used to irrigate and prevent tissue 
desiccation while connective tissue was blunt dissected.  Special care was taken 
not to contact the neurovascular bundle in order to simulate every aspect of the 
ligation except the vascular insult. Finally, the skin incision was closed with 7.0 
polypropylene suture. The mouse then received a subcutaneous injection of 
buprenorphine (0.075 mg/kg) and was allowed to recover on a hot pad until 
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ambulatory (Appendix K). Mice were then returned to the Cal Poly vivarium for 2 
weeks before the vascular casting procedure.  
 The Cal Poly vivarium is maintained at 73±5.0°F and lights are on a 12 
hour light-dark cycle. Each micro-isolator cage houses no more than 4 mice and 
is changed at least once per week. Mice are provided food and water ad libitum, 
in addition to the following enrichments: mouse house, nesting material, and a 
plastic tube. During cage changes, lab members wore isolation outfits that 
included: full gown, gloves, face mask, bonnet, and booties to preserve aseptic 
conditions. Further, mice were monitored on a daily basis, during which their 
health and any irregularities were recorded and/or addressed as necessary. 
 
Imaging 
Sample images were taken using a QImaging Retiga EXi camera at 4x 
magnification on an Olympus BX41 microscope using bright field microscopy 
(Figure 19). QCapture Pro was used to capture the images after adjusting for 
maximum contrast. Because of the size of the gracilis and the level of resolution 
needed for morphological measurements, multiple images of the sample were 
taken and then stitched together into a photomontage using the photomerge 
function in Adobe Photoshop CS3 (Appendix M).  
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Manual Measurement using ImageJ 
Before measuring morphological parameters in a sample, branching order 
was determined using the Strahler method. Strahler ordering begins by defining 
the terminal branches of a given circulation. The terminal branches were 
assigned 1. When two vessels of equal order come together (i.e. order n) at a 
node or branch point, the parent vessel is assigned the next highest order, i.e. 
n+1 (Figure 20A). When two vessels of unequal order come together at a node 
or branch point (i.e. order n and n-2), the parent vessel is labeled order n (Figure 
20B). Once all vessels were ordered morphological measurements were 
obtained using the macro (described in chapter 3) or by manual methods 
B 
A 
Figure 19 – Bright field microscopy setup. A) QImaging Retiga EXi 
camera. B) Olympus BX41 microscope.  
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(Appendix L) and vessel counts were gathered from the total diameter 
measurements.  
Statistical Analysis 
JMP was the software packaged used for the statistical analysis. The 
experiment aimed to answer two questions: 1) does the sham surgery accurately 
reflect the true control, and 2) is there a difference in vessel morphology in the 
transverse arteriolar trees between the ligated and non-ligated samples? The 
answer to the first question determined whether the ligated limbs were compared 
to the sham limbs or to the true control limbs i.e. the samples from Chapter 2, 
where only a vascular cast was performed without surgical intervention. Before 
the statistical analysis, each sample was organized and measured. Each sample 
was ordered (Figure 20) and if a sample didn’t have order 5 vessels it was 
labeled as a poor cast and the data was excluded from the statistical analysis. Of 
Figure 20 – A) When two vessels of order n meet, the parent vessel is 
defined as order n+1. B) When a vessel of order n and a vessel of order n-1 
meet, the parent vessel is labeled an order n. 
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the 32 total samples 9 were labeled as poor fills. Once the sample was ordered, 
each ordered vessel’s length and diameter was recorded and averaged so that 
for a given sample there was an average length and diameter for each individual 
order. Order 6 diameter values were taken from 5 measurements along the 
longitudinal arteriole, from the saphenous artery to the profunda femoris, which 
were then averaged. Order 6 length measurements were not taken. Because 
there were multiple orders and therefore multiple measurements per sample a 
repeated measures analysis was performed in JMP (Appendix J); statistical 
significance (p<0.05) between each condition was assessed using the Tukey-
Kramer test (Appendix I).  When comparing sham legs to ligated legs, a block 
was placed on the mouse to eliminate mouse-to-mouse variability within the 
results. Statistical significance of vessel counts (p<0.05) between the two 
treatments across each order was assessed using t-tests (Appendix N).    
Results 
From the eight ligated mice, replicates C and H were labeled as a poor 
casts and were excluded from analysis. From the true controls, replicates A, C 
and the right leg from H were excluded (Appendix F). Figure 21 depicts a 
successful vascular cast on a ligated animal. 
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Average lengths and diameters from the samples (Appendix G) were 
used to calculate the least square means for each order. The right leg values 
from the ligated animals (sham) were compared to the right leg values from the 
animals only casted using Microfil (true control) to examine if the sham surgery 
was an appropriate estimation of normal. Comparing control and sham found a 
significant difference in the order 5 for length measurements (Figure 22A). No 
significant differences were found between sham and control for diameter 
measurements (Figure 22B). Comparing vessel counts between treatments 
across each order showed no significant differences (Figure 23A); there was 
also no significant differences between sham and ligated legs for length 
measurements (Figure 23B). Comparing sham and ligated legs for diameter 
Figure 21 – Ligated animal E. A) Right leg – Sham surgery. B) 
Left leg – Ligated. 
B 
A 
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measurements found a significant difference in the order 6 measurements 
(Figure 23C).  
 
 
Figure 22 – Right legs (sham) of the ligated mice compared to 
the right legs of the control mice (Microfil only). A) Length 
measurements – significance found between control and sham 
at order 5 only. B) Diameter measurements – no significance 
found between any orders 
A 
B 
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Figure 23 – Right legs of ligated mice (sham) compared to the left legs of ligated 
mice (ligated).  A) Vessel counts – no significance found. B) Length measurements 
– no significance found. C) Diameter measurements – significance found between 
sham and ligated legs at order 6 only. 
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Discussion 
Many factors contribute to the pathophysiology of PAD (46); therefore, a 
mouse model was used to model one aspect of the pathology: an arterial 
occlusion. The occlusion offered an increase in blood flow to the collateral circuit 
in order to examine whether arteriogenesis impacts the transverse arteriole 
architecture branching from the collateral. This could allow a better 
understanding into how therapies to stimulate arteriogenesis would impact the 
microvasculature and tissue function.  
Comparing the sham surgery versus the right leg of the true controls 
yielded a significant difference between the lengths of the order 5 vessels, with 
the sham lengths being significantly greater than the control lengths. Although we 
see this difference in the order 5 lengths of the sham and control samples, this 
alone is not enough to say that the sham surgery cannot be used to estimate the 
true control.  Poiseuille’s law states that, all else being equal, an increase in 
length will result in a decrease in volumetric flow. However, the length is not as 
powerful of a factor as the radius of the vessel and there aren’t any significant 
differences in the order 5 or even the order 6 diameters. This difference in length 
is likely not a reflection of differences in the underlying biology, but rather a 
reflection of insufficient replicates and therefore the sham can be used as a 
control and simply opening the animal for surgery will not cause any significant 
vessel remodeling for our purposes.  
Comparing the sham leg to the ligated leg yielded a significant difference 
between the diameters of the order 6 vessels. To reiterate, the order 6 vessels 
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refer to the collateral arteriole that runs from the profunda femoris to the 
saphenous artery. Arteriogenesis in this vessel is well-described (16), and is 
induced by the elevated flow (shear stress) that is resultant of an increased 
pressure gradient across the collateral vessel following ligation. Increased sheer 
stress is a trigger for increases in arterial diameter and outward remodeling of the 
arterial wall will occur to normalize the hemodynamic shear stress (4, 19, 38). So, 
one reason why the elevated flow didn’t alter transverse arteriolar architecture is 
because the increased hemodynamic shear stress caused by the ligation had 
dissipated by the time the transverse arteriolar level was reached due to the 
arteriogenesis seen in the collaterals. Another explanation could be due to 
cellular communication between gap junctions that override the hemodynamic 
stimuli and cause the network to remain relatively unchanged. Therefore, it’s 
possible that stimulating arteriogenesis in a clinical environment should not 
cause any negative effects in the collateral-containing muscle. However, this 
observation is potentially limited by the differences between the ligation model 
and a patient. 
The femoral artery ligation model is a simplified model of a patient with 
PAD (it only simulates an occlusion), which is why it’s important to understand 
the differences between the model and PAD.  One of the main differences is the 
cause for the conditions, which are significantly different. When the femoral 
artery is ligated, the arterial occlusion occurs quickly, as the suture is pulled taut. 
In the case of a patient with PAD, occlusion occurs as a result of atherosclerosis, 
which occurs gradually as the build-up of plaque causes the narrowing of the 
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arteries over many years (46), however, when a thrombus forms, partial 
occlusion transitions to complete occlusion rapidly. In patients with PAD, 
complete occlusion of arteries often results in limb necrosis without proper 
treatment (10-40% have primary amputations and there is a mortality rate of 40-
70% in 5 years) (14). Further, humans with PAD typically present with other co-
morbidities like heart disease or obesity and have a gradual arterial narrowing 
due to atherosclerosis at multiple vascular sites throughout the body (46). It is 
likely that these co-morbidities explain the lack of revascularization. This results 
in a slower impairment of blood flow and progression of hypoxia and could alter 
the mechanisms for vascular repair (46). Conversely, in the mouse, hindlimb 
revascularization occurs and the mouse is able to recover over a period of 2-4 
weeks sans intervention or treatment (34). The ligation model results in an 
arterial occlusion at one point, so, while both PAD and the model induce an 
occlusion in the extremities and hindlimb, respectively, the mechanisms are 
different. It is important to be aware of these differences as one interprets 
experimental results and makes conclusions regarding the process of 
revascularization and how it may influence recovery of vascular function following 
arterial occlusion when using a mouse model. 
Interesting future experiments could gather branch angle measurements 
to add to the analysis. Further, flow measurements could be taken for the whole 
muscle to examine the impact of architecture versus reactivity or experiments 
could examine the impact architecture has on vasodilation. Future applications of 
this research could try to address one of the major concerns with therapeutic 
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angiogenesis: tumor-like microcirculation. Previous experiments delivering basic 
FGF or VEGF developed stable vascular networks; however, they soon began to 
resemble immature tumor vasculature (11, 14). It’s important to understand why 
that happened by better understanding the network repair process. This study 
examined the repair process in a simple animal model, so the next step would 
either be to examine different muscles in a hypoxic area or to deliver growth 
factors and see how the network changes, which could eventually lead to finding 
what morphology values differentiate a healthy network from a tumor network 
and how a network can be prevented from diverging from stable to tumor-like. 
Other experiments would examine the role of gap junction communication in 
network remodeling by performing similar experiments in connexin knockout 
mice.  
Before proceeding with future experiments it would be advantageous to 
investigate new methods to make data collection more efficient. Measuring the 
samples requires a high level of resolution for order 1 vessels; 15-25 
photomicrographs must be captured and then montaged, sometimes manually. 
Ideally, a high-resolution camera would capture a full sample image with enough 
detail that measurement of order 1 vessels is possible. High resolution cameras 
capable of this task exist but are available in the $40,000 range. A more plausible 
solution would be to capture up-close representative images. This would require 
identification of the large transverse arteriole trees that reach order 5 vessels; 
these arteriole trees would be ordered and measured and would give a sufficient 
representation of the vascular network. Of the samples prepared there were 
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between two and five of these arteriole trees per sample, on average. Capturing 
only the large transverse trees would decrease the images needed from between 
15 and 25 for an entire sample to between 5 and 15 to capture the chosen trees.  
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Chapter 5 - Discussion 
Previous studies have revealed the complexity of vascular remodeling (19, 
31, 38) and relatively simple treatments in clinical trials have yielded less than 
optimal results (11, 14). In order for therapeutic angiogenesis to be successful, 
there needs to be a more comprehensive understanding of the vascular growth 
process to understand why therapeutic angiogenesis was unsuccessful in clinical 
trials. A more complete understanding of the effects of revascularization on 
vascular network topology could provide information to devise more efficacious 
therapeutic angiogenesis treatments for patients with PAD.  
The overall objectives of this study were to establish procedures to 
increase the efficiency of microvascular network morphology and use these 
procedures to investigate microvascular remodeling following arteriogenesis.  
The aims for the thesis were as follows: 
1) Create a vascular casting protocol to only cast the arterial side of the 
microcirculation. 
2) Decrease the time to measure microvascular morphology through some 
form of automation.  
3) Determine the impact of collateral artery enlargement on the topology of 
arteriolar networks that branch from the collateral artery.  
Through Aim 1, I developed a vascular casting protocol to only cast the 
arterial side of the microcirculation with the commercially available casting 
compound Microfil. This protocol required an adjustment of the Microfil viscosity. 
The ideal mixture for casting the arterial side was a ratio of X MV-122 to Y of 
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both the high and normal viscosity diluent (as long as Microfil was prevented 
from entering the lower leg A-V shunt). Because this was successful, the venous 
side no longer complicated the image; this allowed for a more thorough vessel 
identification of arterial trees, trees that were previously lost among the confusion 
of India ink casting were now measurable. When ordering an India ink cast it is 
difficult to discern between arteries and veins, especially for lower ordered 
vessels. This leaves the user to select arterial trees that were easy to identify. 
This results in much lower vessel numbers than the Microfil casting technique.  
Since Microfil casting makes it much easier to identify arterial vessels, more 
vessels were measured (Appendix H) and, therefore, more time was required for 
data collection. Future modifications could order the entire sample and then only 
measure the arteriole trees that reach order 5 before connecting back to the 
longitudinal arteriole. This aim only examined the gracilis, but future work could 
adapt the protocol to include other muscles like the spinotrapezius, and it could 
even be adjusted to fill less of the arterial circulation, depending on the branching 
order of interest.   
Through Aim 2 I decreased the time for morphological measurement of 
the anterior gracilis with a macro written in ImageJ. For this procedure, the vessel 
is defined with four clicks; the macro creates a quadrilateral with the points and 
then measures the two lengths and diameter values to output an average length 
and diameter for the selected vessel. Conversely, manual measurement requires 
separate length and diameter measurements. Surprisingly, results found that the 
macro’s estimation of length was only significantly different for order 5 vessels, 
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where the sample size was small. Overall, the macro is a first step in making 
morphometry measurements more efficient. The next iteration of the process 
would add a vessel angle measurement to the macro, such that all three 
measurements are bundled into one step. One of the unforeseen side effects of 
the new vascular casting protocol was that because the venous vasculature was 
un-casted, arterial vasculature was much easier to identify, which increased 
vessel numbers significantly and therefore inadvertently increased the 
measurement time. To maintain efficiency, focus should be kept on 
measurement of well-casted vascular trees; meaning, after ordering a sample, 
measurements should only be made in vascular trees that reach order 5 before 
connecting back to the longitudinal arteriole. 
For the 3rd and final aim, I used the casting procedure and morphology 
macro, developed in Aims 1 & 2, to compare transverse arteriolar networks 
branching from an enlarged collateral to transverse arteriolar networks branching 
from a non-enlarged collateral. As expected the collateral arteriole (order 6) did 
outwardly remodel. We expected that the increased flow and shear stress in the 
collateral would impact the transverse arteriole networks branching from the 
collateral.  Surprisingly, there was no significant difference for any diameters, 
lengths, or vessel numbers for orders 1 – 5, indicating that the networks aren’t 
significantly changing. This could be due to the lack of hemodynamic shear 
stress (absorbed by the outward remodeling of the collateral arteries), which 
would cause outward remodeling or it could be due to cell-to-cell communication 
through gap junctions overriding the hemodynamic stimuli. 
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 It is important to note that using Microfil as a casting agent doesn’t 
completely eliminate issues arising with discerning vessels for measurement.  
Complex vessel branching patterns necessitate subjective measurement of multi-
directional networks that frequently overlap and intertwine.  The gracilis muscle is 
also three-dimensional, so any vessels in the z-direction may not be measured 
accurately, however, since the gracilis is relatively flat, this likely didn’t impact on 
results.  Another issue identifying vessels stems from inconsistent dissecting of 
the gracilis muscle that leaves some samples with other muscles that underlie 
the gracilis and add layers of vessels that are unwanted. 
Overall, pairing the new Microfil casting technique with the photomerge 
stitching functionality in Photoshop yields an image that shows the larger picture 
of vascular structure following an arterial occlusion. Furthermore, because of the 
high resolution of the images, one is able to make measurements of lower order 
vessels to gather data to explore changes in the vascular structure. The ligation 
model experiments demonstrated functionality of the new techniques and laid the 
groundwork for further experiments to be performed where vascular topology is 
examined rather than vessel cross-sections for the development of PAD 
treatments. Ultimately, more thorough analysis of microvascular network 
topology following arterial occlusion should assist in the development of 
successful therapeutic angiogenesis treatments for patients with PAD. 
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Appendix A 
The following are the true control samples. ACRNI is a full sample label where 
“AC” denotes control animal a, “R” denotes right leg, and “NI” denotes non-
ischemic. 
  
ACLNI 
ACRNI 
BCRNI
BCLNI 
73 
 
 
 
CCRNI 
CCLNI 
DCLNI 
DCRNI 
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ECRNI 
ECLNI 
FCLNI 
FCRNI 
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GCLNI 
GCRNI 
HCLNI 
HCRNI 
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Appendix B – Microfil casting and dissection protocol 
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Appendix C – Program code – Logic comments are displayed in green 
var loc = newArray(0,0,0,0, 0,0,0,0); 
var count = 0; 
var tot = 1; 
 
macro "Sample Tool [a]" { 
 % Prints correct headers 
  if (tot == 1 && count == 0) { 
   print("Pol #,H1 (um),W1 (um),H2 (um),W2 (um),AvgH (um),AvgW (um)"); 
  }  
 % gets x,y,z coordinates on cursor location when “a” is clicked 
       getCursorLoc(x, y, z, flags);  
  loc[count] = x; 
  loc[count + 1] = y; 
  makePoint(x, y); 
  setForegroundColor(0, 0, 0); 
  run("Draw"); 
  count = count + 2; 
 
  if(count > 7) { 
   calc(); 
   count = 0; 
  } 
} 
% Allows user to undo a mistake by pressing “y” 
macro "Clear [y]" {  
 while (count > 0) { 
  run("Undo"); 
  count -= 2; 
 } 
} 
% Uses 8 user defined values from 4 locations to calculate and print calibrated height and width 
function calc() { 
 
 makePolygon(loc[0], loc[1], loc[2], loc[3], loc[6], loc[7], loc[4], loc[5]); 
 setForegroundColor(0, 0, 0); 
 run("Draw"); 
 
 h1 = loc[5] - loc[1]; 
 h2 = loc[7] - loc[3]; 
 w1 = loc[2] - loc[0]; 
 w2 = loc[6] - loc[4]; 
 
 aveH = (h1 + h2) / 2; 
 aveW = (w1 + w2) / 2; 
 
 print(tot + "," + h1 / 0.575 + "," + w1 / 0.575 + "," + h2 / 0.575 + "," 
 + w2 / 0.575 + "," + aveH / 0.575 + "," + aveW / 0.575); 
 
 tot++; 
} 
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Appendix D – How to use Automation Macro Protocol 
To use the tool, first move the automation tool file “automation tool.ijm” 
into ImageJ’s macros folder, most likely found at the path seen in figure A on the 
following page. Next, run ImageJ and click to install a new macro (B). Find 
“automation tool.ijm” and open it. Make sure the “point tool” is selected on the 
ImageJ tool bar and define boxes around a vessel by clicking in the correct order 
(C). Once every vessel has been defined and measured, open the text log and 
save it (D). Next, open excel and choose to open a file; find the saved text log 
from ImageJ (if the text log isn’t found change the file types in Open from “All 
Excel Files” to “All Files”) (E). Upon arrival to the text import wizard; make sure 
“delimited” is checked on the first page (F) and that “tab” is checked on the 
second page (G) and then click finish to get the results in an excel format (H).  
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The steps to install and run the automation tool. A) The most common 
location of the ImageJ macros folder where the “automation tool.ijm” file 
should be copied. B) How to install a new macro. C) The correct click order to 
define a vessel for measurement. D) The log file of measurements that must 
be saved in order to export to excel. E) Select “all files” in order to open your 
log file in excel. F) Import screen 1 – make sure delimited is checked. G) 
Import screen 2 – make sure comma is checked. H) Example of final Excel 
output. 
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Appendix E – Macro versus Manual statistical comparison 
Repeated measures analysis setup in JMP (this window can be accessed in JMP 
by going to Analyze>Fit Model in the toolbar) and Tukey-Kramer results. 
  
  
A B 
Tukey-Kramer Results – A) Diameters B) Lengths 
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Appendix F – Ligated Animal Vascular Casts (NI – Sham Surgery, I – 
Ischemic/Ligated)  
BLI 
BRNI 
ARNI 
ALI 
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CLI 
CRNI 
DLI 
DRNI 
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ELI 
ERNI 
 
  
FLI 
FRNI 
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GLI 
GRNI 
HLI 
HRNI 
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Appendix G – Averages of samples. Order 6 diameters were taken from 5 
measurements along the longitudinal arteriole, from the saphenous artery to the 
profunda femoris, which were then averaged. Order 6 length measurements 
were not taken.  
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Appendix H – Total Vessel Counts 
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Appendix I – JMP output of Tukey-Kramer results for sham versus control 
and sham versus ligated 
  
Sham versus control - Length Sham versus control - Diameter 
Sham versus ligated - Length Sham versus ligated - Diameter 
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Appendix J – Statistical Setup in JMP for sham versus control and sham 
versus ligated 
The screen shots on the following page show how to set up a repeated 
measures analysis in JMP. In the JMP home window access this screen by going 
to Analyze>Fit Model. In the screen shots, behind the fit model window shows 
how the data was organized. The Y variable is what is being measured; for this 
analysis it was either vessel length or diameter. The construct model effects 
window is where the different treatments, experimental units and effects are 
placed for the correct analysis. A) The model fit for the sham versus control 
length analysis. The treatment (sham or control) is nested within the mouse 
variable because treatments were delivered across different mice. B) The model 
fit for the sham versus ligated length analysis. Blocking on the mouse was done 
to remove variability within the experiment because the treatment (sham or 
ligation) was done on the same mouse. This is why the added “Mouse” variable 
is seen in the construct model effects window as well as mouse being crossed 
with treatment instead of being nested as before.  
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Appendix K – Femoral Artery Ligation Checklist 
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Appendix L – Manual Measurement Protocol 
 
1) Calibrate ImageJ (see figure A below) 
2)  Select the freehand lines tool (see figure B below) to trace the vessel 
segments that need measuring.  
3) Press <Ctrl+M> to measure the segment length. Note: Vessel length and 
diameter need to be measured separately, and it’s easiest to measure a 
vessels length, followed by the diameter, as opposed to measuring all the 
lengths and then all the diameters, which makes it difficult to organize in 
the results window. Measurements can then be copied into Excel to be 
analyzed. 
  
B 
A 
Steps to measure an image manually in ImageJ. A) How to set the 
proper scale. B) How to select the freehand line for tracing a vessel.  
93 
 
Appendix M – Photoshop CS3 Photomerge Protocol 
 
First, open all the files to photomerge, select the photomerge function from 
the automate menu. Next, select all the files to be photomerged. Photomerge will 
attempt to automatically arrange all the images into a single panorama. Because 
of the intricacies of the vessels, photomerge sometimes fails at automatically 
arranging the images. In this instance, manual arrangement is necessary. As a 
check I would name my image files in order to make sure Photoshop arranged 
them properly and for ease of manual arrangement.  
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Appendix N – T-test statistical results for vessel count 
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Appendix O – Image Permissions 
Figure 4 permissions 
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Figure 5 permissions 
 
